BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3962678)

  • 1. Mammary carcinoma: comparison of DNA-content in the primary tumor and the corresponding axillary lymphnode metastases.
    Erhardt K; Auer G
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):29-34. PubMed ID: 3962678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microscopic DNA cytophotometry of axillary lymph node metastasis in mammary carcinomas].
    Tawfik M; Börner P; Krause PH
    Verh Dtsch Ges Pathol; 1990; 74():258-61. PubMed ID: 1708597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
    Erhardt K; Auer GU
    Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases.
    Feichter GE; Kaufmann M; Müller A; Haag D; Eckhardt R; Goerttler K
    Breast Cancer Res Treat; 1989 Jan; 13(1):17-22. PubMed ID: 2706325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary carcinoma: DNA analysis in areas showing different histological features in the same tumor.
    Erhardt K; Auer G
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):21-8. PubMed ID: 3515846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
    Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
    Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
    Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
    Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in locally advanced breast cancer (T3, T4) with special reference to tumor cell DNA content.
    Arnerlöv C; Emdin SO; Roos G; Angström T; Bjersing L; Angquist KA; Larsson LG; Jonsson H
    Acta Oncol; 1988; 27(3):221-6. PubMed ID: 3415850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
    Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
    Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary lymph node metastases associated with small invasive breast carcinomas.
    Maibenco DC; Weiss LK; Pawlish KS; Severson RK
    Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic significance of internal mammary lymph node metastases in breast cancer patients].
    Noguchi M; Ota N; Koyazaki N; Taniya T; Miyazaki I; Mizukami Y
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):295-9. PubMed ID: 1513310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry of breast carcinoma. III. Possible altered kinetics in axillary lymph node metastases.
    Ołszewski W; Darzynkiewicz Z; Rosen PP; Claps ML; Melamed MR
    Anal Quant Cytol; 1982 Dec; 4(4):275-8. PubMed ID: 7165183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients.
    Rosen PP; Kimmel M
    Hum Pathol; 1990 May; 21(5):518-23. PubMed ID: 2338331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.
    Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S
    Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of DNA content in primary and lymph node metastases in prostate adenocarcinoma.
    Babiarz J; Peters JM; Miles B; Crissman JD
    Anal Quant Cytol Histol; 1993 Jun; 15(3):158-64. PubMed ID: 8347255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
    Shabani N; Mylonas I; Kunert-Keil C; Briese V; Janni W; Gerber B; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1761-4. PubMed ID: 16033096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.